Corrigendum to " Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease" [Neurobiology of Disease127 (2019) 163-177]
Neurobiol Dis. 2024 Feb:191:106397.
doi: 10.1016/j.nbd.2023.106397.
Epub 2024 Jan 12.
1 Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
2 Neurological Disorders Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
3 Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
4 Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Division of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: emasliah@UCSD.edu.
5 Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System San Diego, CA, USA.